C Carbon

471 total citations
38 papers, 333 citations indexed

About

C Carbon is a scholar working on Pharmacology, Molecular Medicine and Infectious Diseases. According to data from OpenAlex, C Carbon has authored 38 papers receiving a total of 333 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pharmacology, 10 papers in Molecular Medicine and 8 papers in Infectious Diseases. Recurrent topics in C Carbon's work include Antibiotics Pharmacokinetics and Efficacy (13 papers), Antibiotic Resistance in Bacteria (10 papers) and Antibiotic Use and Resistance (4 papers). C Carbon is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (13 papers), Antibiotic Resistance in Bacteria (10 papers) and Antibiotic Use and Resistance (4 papers). C Carbon collaborates with scholars based in France, Sweden and Australia. C Carbon's co-authors include Richard Bax, Philippe Montravers, Laurent Massias, Antoine Andremont, A Contrepois, K. J. Christiansen, Otto Cars, S. Ragnar Norrby, Robert Farinotti and Eric Rubinstein and has published in prestigious journals such as Gastroenterology, The Journal of Infectious Diseases and Antimicrobial Agents and Chemotherapy.

In The Last Decade

C Carbon

33 papers receiving 306 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C Carbon France 10 112 108 98 69 65 38 333
Gary Milkovich United States 13 80 0.7× 87 0.8× 56 0.6× 50 0.7× 66 1.0× 26 423
C. K. Johnson United States 9 95 0.8× 105 1.0× 66 0.7× 91 1.3× 119 1.8× 12 389
Edward L. Goodman United States 7 136 1.2× 107 1.0× 74 0.8× 29 0.4× 113 1.7× 10 358
Matthew F. Wack United States 10 204 1.8× 197 1.8× 72 0.7× 78 1.1× 82 1.3× 15 443
Brent W. Gunderson United States 12 185 1.7× 101 0.9× 43 0.4× 167 2.4× 51 0.8× 15 455
Helen M. Crowe United States 9 62 0.6× 126 1.2× 68 0.7× 34 0.5× 44 0.7× 16 262
Athena L V Hobbs United States 10 121 1.1× 129 1.2× 93 0.9× 65 0.9× 68 1.0× 31 355
Konstantinos N. Fragoulis Greece 7 101 0.9× 111 1.0× 77 0.8× 128 1.9× 32 0.5× 11 337
Jennifer E Girotto United States 12 123 1.1× 143 1.3× 83 0.8× 72 1.0× 68 1.0× 35 372
Bruce Dalton Canada 11 139 1.2× 127 1.2× 148 1.5× 102 1.5× 64 1.0× 29 385

Countries citing papers authored by C Carbon

Since Specialization
Citations

This map shows the geographic impact of C Carbon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C Carbon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C Carbon more than expected).

Fields of papers citing papers by C Carbon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C Carbon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C Carbon. The network helps show where C Carbon may publish in the future.

Co-authorship network of co-authors of C Carbon

This figure shows the co-authorship network connecting the top 25 collaborators of C Carbon. A scholar is included among the top collaborators of C Carbon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C Carbon. C Carbon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Norrby, S. Ragnar & C Carbon. (2005). Report of working group 3: Specialist training and continuing medical education/professional development in the infection disciplines. Clinical Microbiology and Infection. 11. 46–49. 9 indexed citations
2.
Carbon, C. (2005). Continuing professional development and clinical governance: the role of scientific societies. Clinical Microbiology and Infection. 11. 24–27. 4 indexed citations
3.
Carbon, C, Otto Cars, & K. J. Christiansen. (2002). Moving from recommendation to implementation and audit: Part 1. Current recommendations and programs: a critical commentary. Clinical Microbiology and Infection. 8. 92–106. 17 indexed citations
4.
Launay, Odile, et al.. (2001). Endocardites à sur prothèse : six observations. La Revue de Médecine Interne. 22(10). 948–958. 3 indexed citations
5.
Carbon, C & Richard Bax. (1998). Regulating the use of antibiotics in the community. BMJ. 317(7159). 663–665. 55 indexed citations
6.
Carbon, C & P Léophonte. (1997). Recommandations posologiques concernant l'amoxicilline et l'amoxicilline-acide clavulanique dans les pneumonies communautaires de l'adulte à l'hôpital. Médecine et Maladies Infectieuses. 27. 73–78. 2 indexed citations
7.
Carbon, C, et al.. (1995). [Assessment of the role of enterocyte ion exchange in the intestinal absorption of amoxicillin, based on a study of the interaction with amiloride].. PubMed. 43(7). 590–5. 4 indexed citations
8.
Ledésert, Bernard, et al.. (1994). The Impact of a Comprehensive Multi-dimensional Geriatric Assessment Programme on Duration of Stay in a French Acute Medical Ward. Age and Ageing. 23(3). 223–227. 10 indexed citations
9.
Rubinstein, Eric, et al.. (1994). The Intestinal Elimination of Ciprofloxacin in the Rat. The Journal of Infectious Diseases. 169(1). 218–221. 31 indexed citations
10.
Montravers, Philippe, Antoine Andremont, Laurent Massias, & C Carbon. (1994). Investigation of the Potential Role of Enterococcus faecalis in the Pathophysiology of Experimental Peritonitis. The Journal of Infectious Diseases. 169(4). 821–830. 51 indexed citations
11.
Carbon, C. (1993). Experimental endocarditis: a review of its relevance to human endocarditis. Journal of Antimicrobial Chemotherapy. 31(suppl D). 71–85. 30 indexed citations
12.
Fantin, B., et al.. (1991). [Hemorrhagic bursitis infected by Enterobacter cloacae].. PubMed. 20(36). 1787–1787. 3 indexed citations
13.
Abel, Laurent, et al.. (1986). Apheresis in the management of loiasis with high microfilariaemia and renal disease.. BMJ. 292(6512). 24.1–24. 9 indexed citations
14.
Brion, N, et al.. (1986). [Is systematic syphilis serology still useful in a department of internal medicine? A one-year prospective study using a diagnostic and therapeutic decision algorithm].. PubMed. 15(37). 1851–4. 2 indexed citations
15.
Carbon, C, N Brion, & A Contrepois. (1984). Jusqu'où la pharmacocinétique sérique permet-elle de prévoir l'efficacité clinique d'un nouvel antibiotique ?. Médecine et Maladies Infectieuses. 14. 227–232.
16.
Meier, Friedegund, et al.. (1981). Sulfinpyrazone Does Not Alter the Pharmacokinetics of Acebutolol. Journal of Cardiovascular Pharmacology. 3(2). 403–405. 4 indexed citations
17.
Coste, F, et al.. (1980). [A case of indigenous Legionnaires' disease].. PubMed. 9(24). 1707–1707.
18.
Carbon, C, et al.. (1978). Tissue cage experiments with beta-lactam antibiotics in rabbits.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 127–34. 10 indexed citations
19.
Carbon, C, et al.. (1976). La maladie veino-occlusive du foie: situation nosologique et difficultés diagnostiques. 52(16). 2 indexed citations
20.
Carbon, C, et al.. (1971). [Diagnostic problems in a case of African human trypanosomiasis].. PubMed. 63(6). 685–91. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026